Capecitabine

NDC 59651-205 · Aurobindo Pharma Limited

Generic nameCapecitabine

Dosage formTABLET

RouteORAL

Active ingredient(s)CAPECITABINE

Strength500 mg/1

Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]

Marketing categoryANDA

Packages

59651-205-08 — 120 TABLET in 1 BOTTLE (59651-205-08)

59651-205-10 — 1 BLISTER PACK in 1 CARTON (59651-205-10) / 10 TABLET in 1 BLISTER PACK

J8522 — Capecitabine, oral, 50 mg Medicare Part B payment limit (ASP + 6%): $0.08

FDA lists these products with the same active ingredient.

0093-7474 — Capecitabine, 16729-072 — CAPECITABINE, 16729-073 — CAPECITABINE, 31722-774 — capecitabine, 31722-775 — capecitabine, 51407-639 — Capecitabine, 51407-640 — Capecitabine, 55111-496 — capecitabine, 55111-497 — capecitabine, 59651-204 — Capecitabine, 60687-149 — Capecitabine, 61269-475 — capecitabine, 62756-238 — Capecitabine, 62756-239 — Capecitabine, 67877-458 — Capecitabine, 67877-459 — Capecitabine, 68001-487 — CAPECITABINE, 68001-488 — CAPECITABINE, 68001-643 — Capecitabine, 68001-644 — Capecitabine, +15 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.